| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,361,000 |
| Market
Cap: |
722.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.25 - $15.25 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgraw Benjamin F III |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
|
- |
|
| Mehra Anand |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
|
- |
|
| Duyk Geoffrey M |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
|
- |
|
| Goldberg Murray A |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
1,700 |
|
- |
|
| Cagle Gerald D. |
Director |
– • – |
2015-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,700 |
3,554 |
|
- |
|
| Levy Brian |
Chief Medical Officer |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,313 |
16,313 |
|
- |
|
| Anido Vicente Jr |
Chief Executive Officer |
• • – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,188 |
50,188 |
|
- |
|
| Mitro Thomas A |
President and COO |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
11,875 |
16,875 |
|
- |
|
| Kopczynski Casey C. |
Chief Scientific Officer |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,188 |
169,079 |
|
- |
|
| Rubino Richard J |
Chief Financial Officer |
• – – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,063 |
390,097 |
|
- |
|
| Cagle Gerald D. |
Director |
– • – |
2015-02-05 |
4 |
B |
$24.54 |
$12,270 |
D/D |
500 |
4,554 |
2.39 |
- |
|
| Cagle Gerald D. |
Director |
– • – |
2015-02-04 |
4 |
B |
$25.60 |
$12,800 |
D/D |
500 |
4,054 |
2.39 |
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2015-01-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,139,447) |
0 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2015-01-08 |
4 |
S |
$31.11 |
$5,444,250 |
D/D |
(175,000) |
3,324,259 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2015-01-05 |
4 |
S |
$30.67 |
$728,913 |
D/D |
(23,620) |
3,499,259 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2014-12-29 |
4 |
S |
$30.03 |
$186,606 |
D/D |
(6,214) |
3,522,879 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2014-12-26 |
4 |
S |
$30.05 |
$2,239,026 |
D/D |
(74,510) |
3,529,093 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2014-12-23 |
4 |
S |
$30.00 |
$7,890 |
D/D |
(263) |
3,603,603 |
|
- |
|
| Wheeler Kurt |
10% Owner |
– – • |
2014-12-22 |
4 |
S |
$30.36 |
$1,501,029 |
D/D |
(49,441) |
3,603,866 |
|
- |
|
| Coulter James G |
Former 10% Owner (2)(3)(4) |
– – – |
2014-11-25 |
4 |
S |
$25.97 |
$33,761,000 |
I/I |
(1,300,000) |
2,087,466 |
|
- |
|
| Mehra Anand |
Director |
– • – |
2014-11-25 |
4 |
S |
$26.00 |
$20,800,000 |
I/I |
(800,000) |
766,657 |
|
- |
|
| Acmp Iv Llc |
10% Owner |
– – • |
2014-07-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,000,000) |
616,099 |
|
- |
|
| Powell Michael |
10% Owner |
– – • |
2014-07-10 |
4 |
S |
$25.81 |
$207,030 |
D/D |
(8,022) |
0 |
|
- |
|
| Mehra Anand |
10% Owner |
– – • |
2014-07-10 |
4 |
S |
$25.81 |
$207,030 |
I/I |
(8,022) |
0 |
|
- |
|
| Coulter James G |
10% Owner |
– – • |
2014-07-10 |
4 |
S |
$25.28 |
$12,640,000 |
I/I |
(500,000) |
3,387,466 |
|
- |
|
333 Records found
|
|
Page 13 of 14 |
|
|
